(Q39922538)

15 September 2017

A recombinant replication-defective human adenovirus type 3: a vaccine candidate (English)

1 reference

15 September 2017

1 reference

Haitao Li

1

1 reference

15 September 2017

Rong Zhou

2

1 reference

15 September 2017

Jingxian Chen

3

1 reference

15 September 2017

Xingui Tian

4

1 reference

15 September 2017

Qiwei Zhang

5

1 reference

15 September 2017

Qiyi Zeng

6

1 reference

15 September 2017

Sitang Gong

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

31 October 2008

1 reference

15 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

15 September 2017

27

1 reference

15 September 2017

1

1 reference

15 September 2017

116-122

1 reference

Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture

15 September 2017

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

inferred from DOI database lookup

7 January 2021

based on heuristic

Recovery of new agent from patients with acute respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES INCLUDING ADENOVIRUS TYPE 7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Large epidemic of respiratory illness due to adenovirus types 7 and 3 in healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Adenovirus tumor-specific transplantation antigen is a function of the E1A early region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

A rapid and simple method for preparation of adenovirus DNA from infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

Hexon gene switch strategy for the generation of chimeric recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.032

10.1016/J.VACCINE.2008.10.032

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference